Epitomee Medical

Focus: Epitomee Medical is a biotechnology company headquartered in Israel specializing in ingestible devices for weight loss. The company was founded in 2001 and operates as a public entity in the growing obesity intervention market.

Metabolic Diseases

Profile data last refreshed Yesterday · AI intelligence enriched 2w ago

Funding Stage

PUBLIC

Open Jobs

About Epitomee Medical

AI assessmentNot Hiring

No open roles listed right now. Follow Epitomee Medical to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

4 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

Epitomee Capsule

Overweight and Obesity

N/A

Clinical Trials (1)

NCT04994769The Effect of Extended Use of the EPITOMEE CAPSULE (ELECT)

N/A

Help build intelligence for Epitomee Medical

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Focused player in the high-growth weight loss/obesity treatment market with clear therapeutic specialization
Two-decade-old company with public status suggests established operations and stability
Ingestible device technology represents a differentiated approach in a crowded weight loss space

Watch Out For

No active job openings currently listed, indicating minimal near-term hiring or potential organizational contraction
Absence of pipeline data, clinical trial information, and financial metrics prevents assessment of R&D momentum and commercial viability

Generated by Claude from Epitomee Medical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Epitomee Capsule

Overweight and Obesity

N/A

Clinical Trials (1)

NCT04222322The Effect of Epitomee Capsule on Body Weight in Patients With Overweight and Obesity

N/A

Epitomee Device

Overweight and Obesity

N/A

Clinical Trials (1)

NCT04485936Evaluation of the Effect of Epitomee Device on Gastric Emptying Rate in Healthy Subjects

N/A

Epitomee Device

Overweight

N/A

Clinical Trials (1)

NCT03610958Safety and Performance Evaluation of the Epitomee Device for Enhancing Satiety and Weight Loss.

N/A

Open Jobs (0)

No open positions listed yet.

Interview Prep Quick Facts

Founded: 2001

Portfolio: 4 clinical trials

Top TAs: Metabolic Diseases

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo

Therapeutic Area Focus

Metabolic Diseases

4 pipeline

Marketed

Pipeline